Literature DB >> 14979601

Mycobacteraemia among HIV-1-infected patients in São Paulo, Brazil: 1995 to 1998.

D J Hadad1, M Palaci, A C C Pignatari, D S Lewi, M A S Machado, M A S Telles, M C Martins, S Y M Ueki, G M Vasconcelos, M C A Palhares.   

Abstract

From July 1995 to August 1998, mycobacterial blood cultures were obtained from 1032 HIV-infected patients seen at the Centro de Referência e Treinamento de AIDS (CRTA), Hospital São Paulo (HSP), and Centro de Referência de AIDS de Santos (CRAS). Overall, 179 episodes of mycobacteraemia were detected: 111 (62.0%) at CRTA, 50 (27.9%) at HSP, and 18 (10.1%) at CRAS. The frequency of positive cultures declined sharply from 22.6% in 1995 to 6.9% in 1998, consistent with the decrease in opportunistic infections following the publicly funded distribution of highly active antiretroviral therapy. In 1995, mycobacteraemia was more frequently due to Mycobacterium avium complex (59.2%) than Mycobacterium tuberculosis (28.6%), whereas in 1998 the relative frequencies were reversed (28.6 vs. 64.3% respectively), probably justified by the increased virulence of M. tuberculosis and the greater risk of invasive infection in less-immunocompromised patients, including patients unaware they are infected with HIV.

Entities:  

Mesh:

Year:  2004        PMID: 14979601      PMCID: PMC2870089          DOI: 10.1017/s0950268803001535

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  3 in total

1.  Mycobacterium tuberculosis (Mtb) isocitrate dehydrogenases show strong B cell response and distinguish vaccinated controls from TB patients.

Authors:  Sharmistha Banerjee; Ashok Nandyala; Raviprasad Podili; V M Katoch; K J R Murthy; Seyed E Hasnain
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

Review 2.  Recent tuberculosis advances in Latin America.

Authors:  Tom Pelly; David A J Moore; Robert Gilman; Carlton Evans
Journal:  Curr Opin Infect Dis       Date:  2004-10       Impact factor: 4.915

3.  Reduction in extrapulmonary tuberculosis in context of antiretroviral therapy scale-up in rural South Africa.

Authors:  J C Hoogendoorn; L Ranoto; N Muditambi; J Railton; M Maswanganyi; H E Struthers; J A McIntyre; R P H Peters
Journal:  Epidemiol Infect       Date:  2017-07-27       Impact factor: 4.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.